Brief: Oncternal Therapeutics Inc - Estimates Cash And Cash Equivalents Were $63.7 Million As Of December 31, 2022
06/01/2023 21:20
Jan 6 (Reuters) - Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS INC - ESTIMATES CASH AND CASH
EQUIVALENTS
WERE $63.7 MILLION AS OF DECEMBER 31, 2022
Further company coverage: ONCT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;